Company Registration No. 07582291 (England and Wales)
LINEAR DIAGNOSTICS LIMITED
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
LINEAR DIAGNOSTICS LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
LINEAR DIAGNOSTICS LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
4
1,626,931
1,626,931
Tangible assets
5
1,110
2,705
1,628,041
1,629,636
Current assets
Debtors
6
131,616
143,444
Cash at bank and in hand
28,880
3,166
160,496
146,610
Creditors: amounts falling due within one year
7
(1,571,473)
(1,341,779)
Net current liabilities
(1,410,977)
(1,195,169)
Net assets
217,064
434,467
Capital and reserves
Called up share capital
558
558
Share premium account
1,480,063
1,480,063
Profit and loss reserves
(1,263,557)
(1,046,154)
Total equity
217,064
434,467

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 29 May 2026 and are signed on its behalf by:
Mr B Farrell
Director
Company registration number 07582291 (England and Wales)
LINEAR DIAGNOSTICS LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2025
31 December 2025
- 2 -
1
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

2
Accounting policies
Company information

Linear Diagnostics Limited is a private company limited by shares incorporated in England and Wales. The registered office is Newstead House, Pelham Road, Nottingham, NG5 1AP.

2.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

2.2
Going concern

The company completed a fundraising and converted all debt including interest in January 2026. Following the fundraising, the directors consider that existing resources provide sufficient funds for operations to continue at their current level until around the end of 2026. The company is in the process of making grant applications and raising funds from external investors. Although it is not certain that additional funds will be received, the directors have an expectation that either the grant application or the fundraising will be successful and have therefore prepared the accounts on a going concern basis.

2.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

2.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

LINEAR DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2
Accounting policies
(Continued)
- 3 -

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Development Costs
10 years from commercial release
2.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
33% Straight Line
Computer equipment
33% Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

2.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

2.7
Financial instruments
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

2.8
Taxation
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

LINEAR DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
2
Accounting policies
(Continued)
- 4 -
2.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
3
2
4
Intangible fixed assets
Development Costs
£
Cost
At 1 January 2025 and 31 December 2025
1,626,931
Amortisation and impairment
At 1 January 2025 and 31 December 2025
-
0
Carrying amount
At 31 December 2025
1,626,931
At 31 December 2024
1,626,931
LINEAR DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
5
Tangible fixed assets
Fixtures, fittings & equipment
Computer equipment
Total
£
£
£
Cost
At 1 January 2025
14,119
8,895
23,014
Additions
704
-
0
704
At 31 December 2025
14,823
8,895
23,718
Depreciation and impairment
At 1 January 2025
12,865
7,444
20,309
Depreciation charged in the year
1,274
1,025
2,299
At 31 December 2025
14,139
8,469
22,608
Carrying amount
At 31 December 2025
684
426
1,110
At 31 December 2024
1,254
1,451
2,705
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
112,328
132,560
Other debtors
19,288
10,884
131,616
143,444
7
Creditors: amounts falling due within one year
2025
2024
£
£
Loans and accrued interest
1,266,740
1,181,521
Trade creditors
15,786
36,379
Taxation and social security
13,090
20,070
Other creditors
275,857
103,809
1,571,473
1,341,779
8
Events after the reporting date

On 23 January 2026 the company completed a fundraising whereby all loans and accrued interest were converted to Ordinary shares, new Ordinary shares were issued (£65,000 equity proceeds) and A Ordinary and B Ordinary shares were converted to Ordinary shares.

2025-12-31 2025-01-01 false false false 29 May 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Professor T Dafforn Mr David Coleman Mr Brendan Farrell Dr R P B Passas Mr Jean-Louis Duprey Mr David Wilson Mr Paramjit Roopra 07582291 2025-01-01 2025-12-31 07582291 2025-12-31 07582291 2024-12-31 07582291 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-12-31 07582291 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 07582291 core:FurnitureFittings 2025-12-31 07582291 core:ComputerEquipment 2025-12-31 07582291 core:FurnitureFittings 2024-12-31 07582291 core:ComputerEquipment 2024-12-31 07582291 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 07582291 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 07582291 core:CurrentFinancialInstruments 2025-12-31 07582291 core:CurrentFinancialInstruments 2024-12-31 07582291 core:ShareCapital 2025-12-31 07582291 core:ShareCapital 2024-12-31 07582291 core:SharePremium 2025-12-31 07582291 core:SharePremium 2024-12-31 07582291 core:RetainedEarningsAccumulatedLosses 2025-12-31 07582291 core:RetainedEarningsAccumulatedLosses 2024-12-31 07582291 bus:Director3 2025-01-01 2025-12-31 07582291 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 07582291 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-01-01 2025-12-31 07582291 core:FurnitureFittings 2025-01-01 2025-12-31 07582291 core:ComputerEquipment 2025-01-01 2025-12-31 07582291 2024-01-01 2024-12-31 07582291 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 07582291 core:FurnitureFittings 2024-12-31 07582291 core:ComputerEquipment 2024-12-31 07582291 2024-12-31 07582291 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 07582291 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 07582291 bus:FRS102 2025-01-01 2025-12-31 07582291 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 07582291 bus:Director1 2025-01-01 2025-12-31 07582291 bus:Director2 2025-01-01 2025-12-31 07582291 bus:Director4 2025-01-01 2025-12-31 07582291 bus:Director5 2025-01-01 2025-12-31 07582291 bus:Director6 2025-01-01 2025-12-31 07582291 bus:Director7 2025-01-01 2025-12-31 07582291 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP